Pravastatin — CAS 81093-37-0

Pravastatin is a competitive inhibitor of HMG-CoA reductase, the rate-limiting enzyme in cholesterol biosynthesis. It is used clinically to reduce elevated total cholesterol, LDL cholesterol, and triglyceride levels, and to reduce the risk of cardiovascular events. Mediocon Inc manufactures Pravastatin API at its GMP-certified facility in Aurangabad, Maharashtra, India.

• Treatment of hypercholesterolemia and mixed dyslipidemia
• Primary prevention of cardiovascular disease in high-risk patients
• Secondary prevention after myocardial infarction or coronary revascularization
• Reduction of stroke and TIA risk in patients with coronary heart disease

• GMP Certified manufacturing facility in Aurangabad, Maharashtra, India
• Full pharmacopoeial compliance: IP / BP / USP standards
• Complete documentation: Certificate of Analysis (CoA), MSDS, Certificate of Origin
• Stringent in-process quality control at every manufacturing stage
• HPLC purity testing and spectroscopic identification (IR, NMR)
• Cold-chain and controlled-environment storage facilities available
• Exported to 40+ countries with full regulatory support